These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20072657)

  • 1. Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients.
    Roodhart JM; Langenberg MH; Vermaat JS; Lolkema MP; Baars A; Giles RH; Witteveen EO; Voest EE
    Neoplasia; 2010 Jan; 12(1):87-94. PubMed ID: 20072657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.
    Karagiannis GS; Bianchi A; Sanchez LR; Ambadipudi K; Cui MH; Anampa JM; Asiry S; Wang Y; Harney AS; Pastoriza JM; Lin Y; Chen X; Jones JG; Entenberg D; Haddad D; Hodges LJ; Duong TQ; Sparano JA; Oktay MH; Branch CA; Condeelis JS
    NPJ Breast Cancer; 2022 Sep; 8(1):101. PubMed ID: 36056005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment.
    Vorontsova A; Kan T; Raviv Z; Shaked Y
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33276524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survival.
    Sayed HAR; Hetta HF; Shafik EA; Zahran AM
    Cancer Immunol Immunother; 2021 Mar; 70(3):755-761. PubMed ID: 32945943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer.
    Ma G; Jiang Y; Liang M; Li J; Wang J; Mao X; Veeramootoo JS; Xia T; Liu X; Wang S
    Ther Adv Med Oncol; 2020; 12():1758835920918470. PubMed ID: 32489429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions.
    Karagiannis GS; Condeelis JS; Oktay MH
    Cancer Res; 2019 Sep; 79(18):4567-4576. PubMed ID: 31431464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration.
    Huizer K; Sacchetti A; Dik WA; Mustafa DA; Kros JM
    J Oncol; 2019; 2019():3560830. PubMed ID: 31428150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment.
    Perelmuter VM; Tashireva LA; Savelieva OE; Denisov EV; Kaigorodova EV; Zavyalova MV; Cherdyntseva NV
    Breast Cancer (Dove Med Press); 2019; 11():209-219. PubMed ID: 31308736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging roles of macrophages in cancer metastasis and response to chemotherapy.
    Sanchez LR; Borriello L; Entenberg D; Condeelis JS; Oktay MH; Karagiannis GS
    J Leukoc Biol; 2019 Aug; 106(2):259-274. PubMed ID: 30720887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response.
    Middleton JD; Stover DG; Hai T
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition and niche construction in a model of cancer metastasis.
    Qian JJ; Akçay E
    PLoS One; 2018; 13(5):e0198163. PubMed ID: 29813117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
    Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
    BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced metastasis: mechanisms and translational opportunities.
    Karagiannis GS; Condeelis JS; Oktay MH
    Clin Exp Metastasis; 2018 Apr; 35(4):269-284. PubMed ID: 29307118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.
    Karagiannis GS; Pastoriza JM; Wang Y; Harney AS; Entenberg D; Pignatelli J; Sharma VP; Xue EA; Cheng E; D'Alfonso TM; Jones JG; Anampa J; Rohan TE; Sparano JA; Condeelis JS; Oktay MH
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.
    Kerklaan BM; Lolkema MP; Devriese LA; Voest EE; Nol-Boekel A; Mergui-Roelvink M; Langenberg M; Mykulowycz K; Stoebenau J; Lane S; Legenne P; Wissel P; Smith DA; Giantonio BJ; Schellens JH; Witteveen PO
    Br J Cancer; 2015 Sep; 113(5):706-15. PubMed ID: 26291057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone.
    Wang L; Du F; Zhang HM; Zhang WJ; Wang HX
    Braz J Med Biol Res; 2015 Aug; 48(8):736-42. PubMed ID: 26108099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment.
    Chen CH; Cheng CT; Yuan Y; Zhai J; Arif M; Fong LW; Wu R; Ann DK
    Oncotarget; 2015 Jun; 6(17):15194-208. PubMed ID: 26015406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.
    Li S; Plouffe BD; Belov AM; Ray S; Wang X; Murthy SK; Karger BL; Ivanov AR
    Mol Cell Proteomics; 2015 Jun; 14(6):1672-83. PubMed ID: 25755294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial progenitor cell: a promising biomarker in clinical oncology.
    Ge YZ; Wu R; Lu TZ; Xin H; Yu P; Zhao Y; Liu H; Xu Z; Xu LW; Shen JW; Xu X; Zhou LH; Li WC; Zhu JG; Jia RP
    Med Oncol; 2015 Jan; 32(1):332. PubMed ID: 25428376
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.